TrialJournal of child and adolescent psychopharmacology2015

Safety and Efficacy from an 8 Week Double-Blind Trial and a 26 Week Open-Label Extension of Asenapine in Adolescents with Schizophrenia.

Robert L Findling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.